Latest News about CRSP
Recent news which mentions CRSP
Who Benefits From Amazon's Stock Split?
March 16, 2022
From Motley Fool
Is CRISPR Therapeutics Stock a Buy Now?
March 16, 2022
From Motley Fool
Here's How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
March 16, 2022
Tickers
CRSP
From Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now
March 14, 2022
From Motley Fool
3 Ark Invest Most-Shorted Stocks to Buy
March 11, 2022
From InvestorPlace
7 Cathie Wood Stocks That Are Worth Buying in March
March 10, 2022
From InvestorPlace
3 Cathie Wood Stocks to Buy
March 09, 2022
From InvestorPlace
From Motley Fool
2 Stocks to Buy No Matter What Happens in March
March 01, 2022
From Motley Fool
Should You Buy Stocks Now? Here's What Warren Buffett Thinks
March 01, 2022
From Motley Fool
Peloton Isn’t the ONLY Takeover Target. What Companies Could Be Bought Out in 2022?
February 23, 2022
From InvestorPlace
Why Jim Cramer Believes Sirius XM Is Inexpensive
February 23, 2022
From Benzinga
CRISPR Therapeutics's Return On Capital Employed Insights
February 16, 2022
Tickers
CRSP
From Benzinga
3 Biotech Stocks to Buy in February
February 16, 2022
From Motley Fool
2 Exciting Trends That Could Shape Healthcare's Future
February 10, 2022
From Motley Fool
Tickers
CRSP
From Motley Fool
Have $3,000? Buying These 3 Stocks Now Just Might Be the Smartest Move You'll Ever Make
February 07, 2022
From Motley Fool
Is this Beaten-Down Biotech Making a Comeback?
February 04, 2022
From Motley Fool
My Top Growth Stock to Buy in February
February 02, 2022
From Motley Fool
Here's What to Know About Vertex Pharmaceuticals' Earnings Report
February 01, 2022
From Motley Fool
5 Top Stocks for February
February 01, 2022
From Motley Fool
3 Biotech Stocks That Could Deliver 5X Gains by 2030
January 30, 2022
From Motley Fool
A Deep Dive Into the Video Game Industry
January 29, 2022
From Motley Fool
Better Biotech Stock: CRISPR Therapeutics or Twist Bioscience?
January 28, 2022
From Motley Fool
Market Dip? Here's Why This Bargain Biotech Is a Smart Buy Now
January 28, 2022
From Motley Fool
3 Green Flags for CRISPR Therapeutics' Future
January 26, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.